AnalysisJuicy Fields' Collapse - What We Know So Far

Juicy Fields’ Collapse – What We Know So Far


JUICY Fields, a cannabis crowdfunding company offering investors outlandish returns, has collapsed in a characteristically complex and opaque fashion. 

This collapse, while dramatic, has come as little surprise to many in the European cannabis industry who have long suspected the company of being fraudulent due to its lack of transparency and ‘promise of huge returns’. 

Despite this widespread concern and Juicy Fields’ inclusion on numerous countries’ warning lists, many continued to sign sponsorship deals and take cash from the company’s relentless marketing efforts. 

With thousands of investors now unable to access millions in funds, and numerous companies suddenly left without a sponsor, questions arise over how complicit the wider industry was in allowing the company to flourish. 

What Happened to Juicy Fields?

There is still a great deal of uncertainty regarding what exactly has happened at Juicy Fields, who is responsible, and whether the entire business was indeed fraudulent. 

As businesses and former employees scramble to distance themselves from the chaos, groups of investors are joining forces to share information and inform international authorities, seeing swathes of documents (few of which can be corroborated or confirmed as accurate) continue to emerge. 

Below, we have constructed a timeline of events that we are able to verify. 

BusinessCann will continue to track the ongoing developments at Juicy Fields, and will be publishing content as the story evolves. If you are an investor or business with any pertinent information regarding Juicy Fields, please get in touch with us here. 

Latest news

Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost

THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms...

European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’, Jazz Pharma Reimbursement Recommendation & Kanabo Climbs

Akanda  Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not...

15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users

THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market...

Malta’s Pioneering Legal Cannabis Club Framework Announced, But Concerns Raised Licence Fees Could Push Many To Black Market

ON Friday (January 27) the Maltese Authority for the Responsible Use of Cannabis (ARUC) announced new guidelines set to...

Cannovum AG Establishes Cultivation Alliance For Germany

PRESS RELEASE CANNOVUM AG is currently founding the premier cultivation alliance for recreational cannabis in Germany. The aim of the...

Jazz Pharmaceuticals Receives NICE Recommendation For The Reimbursement Of Epidyolex (Cannabidiol) For The Treatment Of Seizures Associated With Tuberous Sclerosis Complex In England

PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals ("GW"; now...

Must read

You might also likeRELATED
Recommended to you